National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DC-STAMP, a protein on the surface of
osteoclast precursors (OCPs), can be used as a biologic marker in Psoriatic Arthritis (PsA).
With this marker the investigators hope to learn more about how OCPs develop as well as find
out if DC-STAMP predicts PsA severity and how well treatment works in PsA.